Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: a real-world, large cohort study

Lung cancer remains the primary cause of cancer-related mortality worldwide. Several treatment modalities are available for lung cancer, including surgery, radiation, and chemotherapy. Among the chemotherapeutics available, afatinib has been shown to be effective for those with epidermal growth fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Sheng-Kai, Lee, Meng-Rui, Liao, Wei-Yu, Ho, Chao-Chi, Ko, Jen-Chung, Shih, Jin-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955108/
https://www.ncbi.nlm.nih.gov/pubmed/29805772
http://dx.doi.org/10.18632/oncotarget.25255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955108/
https://www.ncbi.nlm.nih.gov/pubmed/29805772
http://dx.doi.org/10.18632/oncotarget.25255

Ejemplares similares